Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)
Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –
Niagen Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2018 it was -$32.57M. The highest annual figure on record is -$1.78M in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -$32.57M | – |
| FY2017 | Dec 30, 2017 | -$15.87M | – |
| FY2016 | Dec 31, 2016 | -$2.57M | – |
| FY2015 | Jan 2, 2016 | -$1.78M | – |
| FY2014 | Jan 3, 2015 | -$5.01M | – |
| FY2013 | Dec 28, 2013 | -$4.14M | – |
See a number that looks wrong?